Document is current
Any future updates will be listed below
-
Authors
Pfau, Maximilian https://orcid.org/0000-0001-9761-9640
Pfau, Kristina https://orcid.org/0000-0002-3642-3502
- License Information
-
More Information
Article History
Received: 10 November 2025
Accepted: 18 December 2025
First Online: 13 January 2026
Interessenkonflikt
: M. Pfau: Daiichi Sankyo, Inozyme, Bayer, Novartis, F. Hoffmann-La Roche; K. Pfau: Daiichi Sankyo, Inozyme, Catalys Pacific, Roche, Bayer, Novartis.
